BCMLT
TEVA icon

Beacon Capital Management LLC (Tennessee)’s Teva Pharmaceuticals TEVA Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-142
Closed -$2.38K – 907
2025
Q2 		$2.38K Hold
142
– – ﹤0.01% 876
2025
Q1 		$2.18K Hold
142
– – ﹤0.01% 928
2024
Q4 		$3.13K Hold
142
– – ﹤0.01% 809
2024
Q3 		$2.56K Hold
142
– – ﹤0.01% 940
2024
Q2 		$2.31K Hold
142
– – ﹤0.01% 841
2024
Q1 		$2K Hold
142
– – ﹤0.01% 876
2023
Q4 		$1.45K Hold
142
– – ﹤0.01% 828
2023
Q3 		$1.07K Hold
142
– – ﹤0.01% 914
2023
Q2 		$1.07K Hold
142
– – ﹤0.01% 914
2023
Q1 		$1.26K Hold
142
– – ﹤0.01% 816
2022
Q4 		$1.29K Sell
142
-7
-5% -$61 ﹤0.01% 852
2022
Q3 		$1K Hold
149
– – ﹤0.01% 842
2022
Q2 		$1K Hold
149
– – ﹤0.01% 891
2022
Q1 		$1K Buy
+149
New +$1.24K ﹤0.01% 892

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s TEVA Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 142 shares — an estimated $2.38K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in TEVA in Q1 2022 and held it in 14 quarters. The position peaked at $3.13K in Q4 2024. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 142 Teva Pharmaceuticals shares in Q3 2025, an estimated $2.38K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Teva Pharmaceuticals in Q1 2022 and held it in 14 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Teva Pharmaceuticals position peaked at $3.13K in Q4 2024.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.